AIA Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.92M | Buy |
127,990
+33,388
| +35% | +$1.55M | 0.13% | 92 |
|
|
2025
Q1 | $5.77M | Buy |
94,602
+70,858
| +298% | +$4.32M | 0.14% | 80 |
|
|
2024
Q4 | $1.34M | Buy |
23,744
+925
| +4% | +$52.3K | 0.03% | 185 |
|
|
2024
Q3 | $1.18M | Sell |
22,819
-19,862
| -47% | -$1.03M | 0.03% | 206 |
|
|
2024
Q2 | $1.77M | Sell |
42,681
-45,087
| -51% | -$1.87M | 0.05% | 159 |
|
|
2024
Q1 | $4.76M | Buy |
87,768
+31,792
| +57% | +$1.72M | 0.16% | 68 |
|
|
2023
Q4 | $2.87M | Buy |
55,976
+7,290
| +15% | +$374K | 0.12% | 86 |
|
|
2023
Q3 | $2.83M | Buy |
48,686
+8,764
| +22% | +$509K | 0.14% | 82 |
|
|
2023
Q2 | $2.55M | Buy |
39,922
+9,490
| +31% | +$607K | 0.12% | 81 |
|
|
2023
Q1 | $2.11M | Sell |
30,432
-802
| -3% | -$55.6K | 0.11% | 82 |
|
|
2022
Q4 | $2.25M | Sell |
31,234
-35,388
| -53% | -$2.55M | 0.14% | 65 |
|
|
2022
Q3 | $4.74M | Buy |
66,622
+25,468
| +62% | +$1.81M | 0.31% | 36 |
|
|
2022
Q2 | $3.17M | Buy |
41,154
+6,753
| +20% | +$520K | 0.17% | 56 |
|
|
2022
Q1 | $2.51M | Buy |
34,401
+21,122
| +159% | +$1.54M | 0.11% | 86 |
|
|
2021
Q4 | $828K | Sell |
13,279
-73,689
| -85% | -$4.59M | 0.04% | 148 |
|
|
2021
Q3 | $5.15M | Buy |
86,968
+61,982
| +248% | +$3.67M | 0.29% | 57 |
|
|
2021
Q2 | $1.66M | Buy |
24,986
+12,727
| +104% | +$845K | 0.11% | 88 |
|
|
2021
Q1 | $774K | Buy |
+12,259
| New | +$774K | 0.11% | 95 |
|